These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 12825426)

  • 1. Prior agreements in international clinical trials: ensuring the benefits of research to developing countries.
    Page AK
    Yale J Health Policy Law Ethics; 2002; 3(1):35-66. PubMed ID: 12825426
    [No Abstract]   [Full Text] [Related]  

  • 2. Moral standards for research in developing countries: from "reasonable availability" to "fair benefits".
    Participants in the 2001 Conference on Ethical Aspects of Research in Developing Countries
    Hastings Cent Rep; 2004; 34(3):17-27. PubMed ID: 15281723
    [No Abstract]   [Full Text] [Related]  

  • 3. For-profit clinical trials in developing countries--those troublesome patient benefits.
    Schuklenk U
    Am J Bioeth; 2010 Jun; 10(6):52-4. PubMed ID: 20526975
    [No Abstract]   [Full Text] [Related]  

  • 4. Fair benefits in international medical research.
    Arras JD
    Hastings Cent Rep; 2004; 34(3):3. PubMed ID: 15281717
    [No Abstract]   [Full Text] [Related]  

  • 5. Ethics of AIDS clinical trials in developing countries: a review.
    Pitler LR
    Food Drug Law J; 2002; 57(1):133-53. PubMed ID: 12118476
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical trials in "developing" countries: is there a special "Third World" ethic?].
    Rothman DJ
    Z Arztl Fortbild Qualitatssich; 2003 Dec; 97(10):695-702. PubMed ID: 14997587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Back to the rough ground: working in international HIV prevention as ethical debates continue.
    MacQueen KM; Sugarman J
    IRB; 2003; 25(2):11-3. PubMed ID: 12833902
    [No Abstract]   [Full Text] [Related]  

  • 8. Multinational clinical trials in oncology and post-trial benefits for host countries: where do we stand?
    Mano MS; Rosa DD; Dal Lago L
    Eur J Cancer; 2006 Nov; 42(16):2675-7. PubMed ID: 16962315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approaches vary for clinical trials in developing countries.
    Hayasaka E
    J Natl Cancer Inst; 2005 Oct; 97(19):1401-3. PubMed ID: 16204687
    [No Abstract]   [Full Text] [Related]  

  • 10. Deprivation, disease, and the ethics of international research.
    London A
    Bioeth Exam; 2000; 4(1):1, 4. PubMed ID: 14746326
    [No Abstract]   [Full Text] [Related]  

  • 11. Sharing the benefits of genetic resources: from biodiversity to human genetics.
    Schroeder D; Lasén-Díaz C
    Dev World Bioeth; 2006 Dec; 6(3):135-43. PubMed ID: 17038005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing therapies less effective than the best current standard: ethical beliefs in an international sample of researchers.
    Kent DM; Mwamburi M; Cash RA; Rabin TL; Bennish ML
    Am J Bioeth; 2003; 3(2):W11. PubMed ID: 14635629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparations for AIDS vaccine evaluations. AIDS International Training and Research Program.
    Bridbord K
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S227-9. PubMed ID: 7865307
    [No Abstract]   [Full Text] [Related]  

  • 14. Research benefits for hypothetical HIV vaccine trials: The views of Ugandans in the Rakai District.
    Grady C; Wagman J; Ssekubugu R; Wawer MJ; Serwadda D; Kiddugavu M; Nalugoda F; Gray RH; Wendler D; Dong Q; Dixon DO; Townsend B; Wahl E; Emanuel EJ
    IRB; 2008; 30(2):1-7. PubMed ID: 18512653
    [No Abstract]   [Full Text] [Related]  

  • 15. Response to 'HIV vaccine trials: reconsidering the therapeutic misconception and the question of what constitutes trial-related injuries'.
    Slack C; Stobie M
    Dev World Bioeth; 2008 Aug; 8(2):159-61. PubMed ID: 18717887
    [No Abstract]   [Full Text] [Related]  

  • 16. Good enough to use for research, but not good enough to benefit from the results of that research: are the clinical HIV vaccine trials in Africa unjust?
    Yearby R
    De Paul Law Rev; 2004; 53(3):1127-54. PubMed ID: 16200692
    [No Abstract]   [Full Text] [Related]  

  • 17. Ten questions institutional review boards should ask when reviewing international clinical research protocols.
    Fitzgerald DW; Wasunna A; Pape JW
    IRB; 2003; 25(2):14-8. PubMed ID: 12833903
    [No Abstract]   [Full Text] [Related]  

  • 18. The challenge of assuring continued post-trial access to beneficial treatment.
    Grady C
    Yale J Health Policy Law Ethics; 2005; 5(1):425-35. PubMed ID: 15742586
    [No Abstract]   [Full Text] [Related]  

  • 19. Thorny issues in the ethics of AIDS vaccine trials.
    Berkley S
    Lancet; 2003 Sep; 362(9388):992. PubMed ID: 14513850
    [No Abstract]   [Full Text] [Related]  

  • 20. The Global Forum for Bioethics in Research: report of a meeting.
    Loff B; Hofman K; Muthuswamy V
    Issues Med Ethics; 2001; 9(2):63-4. PubMed ID: 16334477
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.